This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

A blood test shows MS worsening one to two years before it happens

disability
Credit: CC0 Public Domain

Multiple sclerosis patients whose blood tests reveal elevated NfL, a biomarker of nerve damage, could see worsening disability one to two years later, according to a new study spearheaded by researchers at UC San Francisco.

The study is the first to quantify the timeframe preceding disability worsening in which injury to the central nervous system takes place, said co-first author Ahmed Abdelhak, MD, of the UCSF Department of Neurology and the Weill Institute for Neurosciences.

Almost 1 million Americans suffer from MS. In advanced cases, patients may have limited mobility and experience spasticity, weakness, poor coordination and incontinence. However, recent advances suggest that more can be substantially delayed or even averted.

"This rising of NfL up to two years before signs of disability worsening, represents the window when interventions may prevent worsening," said Abdelhak.

In the study, published in JAMA Neurology on Nov. 6, 2023, and co-led by University Hospital and University of Basel, in Switzerland, the researchers looked at the incidence of disability worsening, defined as six months or more of increased impairment reflected in a on the Expanded Disability Status Scale. They distinguished between disability worsening with relapse, which involves residual symptoms or the return of old ones following relapse, and gradual progression of symptoms without relapse.

91% at elevated risk of developing disability worsening

The researchers tracked data spanning a 10-year period from approximately 4,000 patient visits to UCSF, comprising the EPIC study, and from approximately 9,000 patient visits to multiple sites in Switzerland, comprising the SMSC study. Together, the two studies included almost 1,900 patients. Among those, 570 patients were identified with disability that continued to worsen, of which the majority were independent of relapses.

Elevated NfL levels were associated with up to a 91% higher risk of worsening disability with relapse approximately a year later, and up to a 49% higher risk of worsening disability without relapse nearly two years later, the researchers found.

"We think that NfL elevation occurs earlier in disability worsening without ," said Abdelhak. This different pattern may indicate "a more prolonged process that decreases in intensity in advance of increased impairment," said co-senior author Ari Green, MD, medical director of the UCSF Multiple Sclerosis and Neuroinflammation Center.

"This aligns with recognition that death of nerve cells is a slow process that builds toward permanent disability and means that interventions to protect might have time to also stop disability," he said.

"In addition to the groundbreaking findings on the temporal relationship between NfL increases and gradual disease progression in MS, the study supports the important role of NfL as an early marker of nerve damage," said co-senior author Jens Kuhle, MD, Ph.D., who led the Swiss cohort and is head of the Multiple Sclerosis Center at University Hospital and University of Basel, Switzerland. "Monitoring NfL levels might be able to detect disease activity with higher sensitivity than clinical exam or conventional imaging," he said.

Future investigation will look into therapies that can stop progression during this period of elevated NfL.

More information: Ahmed Abdelhak et al, Neurofilament Light Chain Elevation and Disability Progression in Multiple Sclerosis, JAMA Neurology (2023). DOI: 10.1001/jamaneurol.2023.3997 , doi.org/10.1001/jamaneurol.2023.3997

Journal information: Archives of Neurology
Citation: A blood test shows MS worsening one to two years before it happens (2023, November 6) retrieved 18 June 2024 from https://medicalxpress.com/news/2023-11-blood-ms-worsening-years.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

New study details the ways patients with multiple sclerosis develop impairment

28 shares

Feedback to editors